Investment Management Corp of Ontario (IMCO)’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.36M Sell
2,516
-400
-14% -$225K 0.02% 507
2026
Q1
$1.73M Sell
2,916
-580
-17% -$289K 0.02% 456
2025
Q4
$1.7M Buy
3,496
+1,469
+72% +$684K 0.02% 468
2025
Q3
$850K Sell
2,027
-3,425
-63% -$1.15M 0.01% 510
2025
Q2
$1.57M Sell
5,452
-7,695
-59% -$2.3M 0.02% 346
2025
Q1
$4.05M Sell
13,147
-16,757
-56% -$5.74M 0.08% 186
2024
Q4
$10.6M Buy
29,904
+18,278
+157% +$6.72M 0.35% 44
2024
Q3
$4.17M Sell
11,626
-228
-2% -$77K 0.09% 158
2024
Q2
$3.78M Buy
11,854
+846
+8% +$224K 0.1% 144
2024
Q1
$2.53M Sell
11,008
-400
-4% -$90.3K 0.08% 182
2023
Q4
$2.51M Buy
11,408
+1,124
+11% +$259K 0.06% 214
2023
Q3
$2.32M Buy
10,284
+5,126
+99% +$1.18M 0.09% 139
2023
Q2
$1.14M Buy
+5,158
New +$1.14M 0.05% 143

Other funds holding UTHR

Investment Management Corp of Ontario (IMCO)'s UTHR Position: Q2 2026 in Review

Investment Management Corp of Ontario (IMCO) reduced its United Therapeutics (UTHR) stake by 14% in Q2 2026, selling an estimated $225K and leaving 2,516 shares worth $1.36M. The position accounts for 0.02% of the portfolio, ranked #507.

Investment Management Corp of Ontario (IMCO) first reported a position in UTHR in Q2 2023 and has held it in 13 quarters since. The position peaked at $10.6M in Q4 2024. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Investment Management Corp of Ontario (IMCO) held 2,516 shares of United Therapeutics worth $1.36M as of Q2 2026.
  • Investment Management Corp of Ontario (IMCO) sold 400 United Therapeutics shares in Q2 2026, an estimated $225K.
  • United Therapeutics made up 0.02% of Investment Management Corp of Ontario (IMCO)'s portfolio in Q2 2026, its #507 holding.
  • Investment Management Corp of Ontario (IMCO) first reported a position in United Therapeutics in Q2 2023 and has held it in 13 quarters since.
  • Investment Management Corp of Ontario (IMCO)'s United Therapeutics position peaked at $10.6M in Q4 2024.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Investment Management Corp of Ontario (IMCO)'s 13F filing for Q2 2026, filed 14 Aug 2026.